|
|
 |
|
Viewing report
|
|
|
|
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
GBI Research, Feb 2010, Pages: 76
“Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs”. The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and clinical services. This pharmaceutical and healthcare report suggests investment decisions in biomarker-based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical trends, mergers and acquisitions and market potential. It also provides an analysis on the trends prevailing in the global biomarkers market. In addition to this, the report covers drivers and restrains for the global biomarkers market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Scope
The scope of this report includes:
- Market Potential and Pipeline Analysis of biomarkers by phase of development, therapeutic class and geography.
- Market Size and forecast of global biomarkers market and biomarkers drug discovery market from 2000 to 2008, forecast forward to 2015.
- Analysis of Key geographies including the US (United States), Europe the UK (United Kingdom), France, Germany, Italy and Spain), Australia and Southeast Asia.
- Investments and Funding Analysis for top companies (Quest Diagnostics, Applied Biosystems, Vermillion, BGMedical, Menarini, Abbott, Roche, Genetech, Affymetrix and Amgen) in the biomarker-based assay development arena. This includes biomarker research on the application and development of novel biomarkers by the top companies and analysis of the competitive factors affecting the global biomarkers market.
- Qualitative analysis of market drivers, market trends, and challenges.
- M&A landscape in the biomarkers space segmented by deal value, geography and phase.
Reasons to buy
The report will improve decision making and will enable you to:
- Develop business strategies by understanding the trends and developments that are driving the biomarkers-based drug research and development.
- Design, develop and expand your product development, marketing and sales strategies based on forecast of global biomarkers and biomarkers drug discovery market till 2015
- Develop business strategies to exploit biomarkers-based drug discovery market in emerging geographies
- Identify the key players positioned to take advantage of the emerging market opportunities
- Exploit M&A opportunities by identifying key market players with the most novel pipeline
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
Companion Biomarkers in Drug Development
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
Biomarkers, Tests and Trends for Drug R&D
Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Biomarkers - Advanced Technologies and Global Market (2009-2014)
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
|
|
|
